http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 21 Jan 2025 17:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong><br/></p> <p align="justify">TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is exploring strategic options for the potential sale of its subsidiary, Canapar Corp., and/or its industrial facility located in Ragusa, Italy.</p> <p align="justify">This decision is part of RAMM&apos;s ongoing efforts to streamline operations and focus on its operating businesses while seeking potential growth opportunities. The potential sale is aimed at enhancing shareholder value and ensuring the long-term sustainability http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html Tue, 21 Jan 2025 17:00:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong><br/></p> <p align="justify">TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is exploring strategic options for the potential sale of its subsidiary, Canapar Corp., and/or its industrial facility located in Ragusa, Italy.</p> <p align="justify">This decision is part of RAMM&apos;s ongoing efforts to streamline operations and focus on its operating businesses while seeking potential growth opportunities. The potential sale is aimed at enhancing shareholder value and ensuring the long-term sustainability http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html Tue, 21 Jan 2025 17:00:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong><br/></p> <p align="justify">TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is exploring strategic options for the potential sale of its subsidiary, Canapar Corp., and/or its industrial facility located in Ragusa, Italy.</p> <p align="justify">This decision is part of RAMM&apos;s ongoing efforts to streamline operations and focus on its operating businesses while seeking potential growth opportunities. The potential sale is aimed at enhancing shareholder value and ensuring the long-term sustainability http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html Tue, 21 Jan 2025 17:00:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong><br/></p> <p align="justify">TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is exploring strategic options for the potential sale of its subsidiary, Canapar Corp., and/or its industrial facility located in Ragusa, Italy.</p> <p align="justify">This decision is part of RAMM&apos;s ongoing efforts to streamline operations and focus on its operating businesses while seeking potential growth opportunities. The potential sale is aimed at enhancing shareholder value and ensuring the long-term sustainability http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html Tue, 21 Jan 2025 17:00:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong><br/></p> <p align="justify">TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is exploring strategic options for the potential sale of its subsidiary, Canapar Corp., and/or its industrial facility located in Ragusa, Italy.</p> <p align="justify">This decision is part of RAMM&apos;s ongoing efforts to streamline operations and focus on its operating businesses while seeking potential growth opportunities. The potential sale is aimed at enhancing shareholder value and ensuring the long-term sustainability http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html Tue, 21 Jan 2025 17:00:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong><br/></p> <p align="justify">TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is exploring strategic options for the potential sale of its subsidiary, Canapar Corp., and/or its industrial facility located in Ragusa, Italy.</p> <p align="justify">This decision is part of RAMM&apos;s ongoing efforts to streamline operations and focus on its operating businesses while seeking potential growth opportunities. The potential sale is aimed at enhancing shareholder value and ensuring the long-term sustainability http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Canapar/24230245.html Tue, 21 Jan 2025 17:00:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong></p> <p align="justify">TORONTO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is providing an update on its dispute with Sergio Martines and Naturale Science Inc. (plaintiffs), as previously reported in its press release of May 21st 2024.</p> <p align="justify">The Judge has dismissed the plaintiffs’ claim in the amount of CAD 3,139,931.30 and has awarded Martines CAD 14,971.80 in unpaid expenses. The Judge has also dismissed RAMM’s counterclaim in the amount of CAD 14,220,000.</p> http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html Wed, 11 Dec 2024 10:46:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong></p> <p align="justify">TORONTO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is providing an update on its dispute with Sergio Martines and Naturale Science Inc. (plaintiffs), as previously reported in its press release of May 21st 2024.</p> <p align="justify">The Judge has dismissed the plaintiffs’ claim in the amount of CAD 3,139,931.30 and has awarded Martines CAD 14,971.80 in unpaid expenses. The Judge has also dismissed RAMM’s counterclaim in the amount of CAD 14,220,000.</p> http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html Wed, 11 Dec 2024 10:46:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong></p> <p align="justify">TORONTO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is providing an update on its dispute with Sergio Martines and Naturale Science Inc. (plaintiffs), as previously reported in its press release of May 21st 2024.</p> <p align="justify">The Judge has dismissed the plaintiffs’ claim in the amount of CAD 3,139,931.30 and has awarded Martines CAD 14,971.80 in unpaid expenses. The Judge has also dismissed RAMM’s counterclaim in the amount of CAD 14,220,000.</p> http://www.streetinsider.com/Press+Releases/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html Wed, 11 Dec 2024 10:46:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong></p> <p align="justify">TORONTO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is providing an update on its dispute with Sergio Martines and Naturale Science Inc. (plaintiffs), as previously reported in its press release of May 21st 2024.</p> <p align="justify">The Judge has dismissed the plaintiffs’ claim in the amount of CAD 3,139,931.30 and has awarded Martines CAD 14,971.80 in unpaid expenses. The Judge has also dismissed RAMM’s counterclaim in the amount of CAD 14,220,000.</p> http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html Wed, 11 Dec 2024 10:46:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong></p> <p align="justify">TORONTO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is providing an update on its dispute with Sergio Martines and Naturale Science Inc. (plaintiffs), as previously reported in its press release of May 21st 2024.</p> <p align="justify">The Judge has dismissed the plaintiffs’ claim in the amount of CAD 3,139,931.30 and has awarded Martines CAD 14,971.80 in unpaid expenses. The Judge has also dismissed RAMM’s counterclaim in the amount of CAD 14,220,000.</p> http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html Wed, 11 Dec 2024 10:46:00 -0500 O.47009847 RAMM RAMMF http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html <p align="center"><strong>Not for Dissemination in the US or through US Newswire Services</strong></p> <p align="justify">TORONTO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “<strong>Company</strong>” or &quot;<strong>RAMM&quot;) (CSE: RAMM)</strong>, is providing an update on its dispute with Sergio Martines and Naturale Science Inc. (plaintiffs), as previously reported in its press release of May 21st 2024.</p> <p align="justify">The Judge has dismissed the plaintiffs’ claim in the amount of CAD 3,139,931.30 and has awarded Martines CAD 14,971.80 in unpaid expenses. The Judge has also dismissed RAMM’s counterclaim in the amount of CAD 14,220,000.</p> http://www.streetinsider.com/Globe+Newswire/RAMM+Pharma+Corp.+Provides+Update+on+Litigation/24092548.html Wed, 11 Dec 2024 10:46:00 -0500 O.47009847 RAMM RAMMF